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Cancer Risk Models for Ionizing Radiation
by David G. Hoel*
Risk estimation in radiation carcinogenesis depends primarily on epidemiological data and hazard rate
models. The A-bomb survivors follow-up provides information on the complexity of this process. Several
hazard rate models are briefly discussed and illustrated using the A-bomb experience.
Introduction
Carcinogenic risk estimation is an especially complex
problem, and its complexity is best illustrated by con-
sidering data on the effects ofionizing radiation. These
data are possibly the most extensive example of a hu-
man health outcome in large numbers ofindividuals ex-
posed to a wide range of doses of both gamma and X-
ray radiation. The data allow one to consider the ade-
quacy ofvarious statistical models for carcinogenic risk
in human populations.
The data have shown that there are many complex
factors involved in trying to predict a cancer risk from
a single agent. Table 1 presents several of the major
radiation issues. The assumptions underlying any one
of these factors can have a profound effect on subse-
quent quantitative estimation and, hence, on any ex-
posure standard or regulation that is derived from such
estimates. This paper briefly discusses some of these
factors using the data from the Japanese A-bomb sur-
vivors. This studyinvolves thefollow-up ofover 100,000
individuals for over 30 years. The data have been con-
sidered the primary data for most analyses of carcino-
genic risk from low linear energy transformation (LET)
radiation (1,2).
Japanese A-Bomb Survivors
The most recent analysis of cancer mortality among
the bomb survivors is given in Preston et al. (3). Those
cancer sites that are related to radiation dose are given
in Table 2. Over 6000 cancer deaths have been recorded
in this population, and they are basically divided into
leukemia and nonleukemia deaths. Deaths are sepa-
rated into these two categories because leukemias occur
early and tend topeak in terms ofexcess incidence after
about 5 to 10 years postexposure. The nonleukemias,
on the other hand, seem to have a 10 to 20 year latency
period, after which the risk is increased and remains at
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Table 1. Factors in radiation cancer risk estimation.
Structure of relative risk functions
Dependence on age-at-exposure
Dependence on spontaneous rates
Dose-response relationships
Dose-rate effects
Biological effectiveness ofradiation type
Interaction with other risk factors
Table 2. Cancer mortality among A-bomb survivors (1950-1982):
Cancer sites that have a statistically significant increasing trend
in radiation.a,b
Radiation risk,
Site 100 rads
Leukemia* 3.95
Nonleukemia* 1.17
Esophagus 1.23
Stomach* 1.11
Colon* 1.38
Liver 1.35
Lung* 1.33
Breast* 1.69
Ovary 1.52
Bladder-kidney* 1.55
Multiple myeloma 1.51
aFrom Preston et al. (3).
bNote: 6270 total cancer deaths, (p S0.05).
cPerson-year-rads.
*p<0.01.
Excess,
106 PYRC
1.51
3.88
0.17
0.96
0.30
0.08
0.82
0.65
0.27
0.24
0.06
an increased rate approximately proportional to the
background or spontaneous rate.
The leukemias are the most noticeable site because
the relative riskis the greatest forthem: 3.95 compared
with 1.17 for nonleukemic cancers. On the other hand,
the nonleukemic cancers are wellahead oftheleukemias
in terms of total excess cancers: 3.88 versus 1.51 per
106 person-year-rads. Those individual cancer sites that
have the greatest excess in the Japanese survivors are
leukemia, followed by stomach, lung, and breast.
The Japanese A-bomb survivor population presents
some specific problems for extrapolating the effects to
other population groups. The amount of excess at a
given cancer site may ormay not depend uponthe spon-
taneous rate of that cancer site. For example, breastD. G. HOEL
cancerinJapanis muchlowerthaninthe U.S., whereas
stomach canceris much higher. Therefore, the question
is how best to extrapolate those effects from Japan to
the U.S. population where the spontaneous rates differ.
Based on other radiation studies in primarily medically
exposed groups in the U.S. and Europe, it has been
concluded [at least for breast cancer (4)] thatthe excess
risk that is not particularly dependent on the sponta-
neous rate should remain approximately constant be-
tween population groups. This is difficult, however, be-
cause ofthe complexityofcomparingthe various studies
and their limitations (5).
Stewart and Kneale (6) raised the issue of possible
survival of the fittest among the A-bomb survivors:
those that received the higher doses and survived are
somehow more resistant to disease than those who did
not. This is borne out somewhat whenone analyzes both
cancer and noncancer deaths due to radiation (Table 3).
For example, one observes an excess of cancer deaths
in males, namely 122 over the period of 1950 to 1982,
using a linear-quadratic dose-response model. On the
other hand, mortality due to other diseases is at a def-
icit. The quadratic terminthe dose response is positive,
so for individuals with midlevel radiation doses there
appears to be a protective effect. The protective effect
may be due simply to survival of the fittest or there
may be some other bias related to exposure that has
yet to be identified. This then yields a total mortality
deficit of 74 for the male population. How or whether
one takes this into account when estimating the dose-
response relationship between cancer mortality and ex-
posure is not clear at this point.
Ageand sexeffectsplayanimportantroleinradiation
carcinogenesis. As shown in Table 3, the excess cancer
deaths were higher in females than males with similar
background numbers. In particular, there is an esti-
mated 206 excess deaths in females compared with 122
in males. Table 4 shows age-sex effects with respect to
leukemia and nonleukemia cancers. Therelative riskfor
leukemias is about the same in both males and females,
but the background rate is about one-half for females
compared to males. On the other hand, the relative risk
ofnonleukemias for females is significantly higher than
formales. Whatthisyieldsisthatthe excessofleukemia
deaths is significantly greater in the males than in the
females: 1.95 versus 1.2 per 106 person-year-rads. The
nonleukemias, however, are higher in the females than
in the males (4.42 versus 3.29), although this latter dif-
ference is not statistically significant. Finally, for the
Table 3. Estimated deaths due to radiation (1950-1982).a
Male Female
Cause of death Excess Background Excess Background
Cancer 122 3106 206 3148
Blood disease 10 49 17 86
Other diseases -166 10921 -49 11881
Other deaths -45 1072 15 655
Total -74 15147 190 15769
aHiroshima and Nagasaki, life-span sample.
susceptibility of age-at-exposure, one sees from Table
4 that individuals exposed before the age of 20 had a
higher relative risk for both leukemias and nonleuke-
mias, withasignificantdifferencefornonleukemias. The
statistics above illustrate the complexity ofattempting
to quantify risks for human populations where sizable
differences exist simply with age-at-exposure and sex
of the individual.
Hazard Rate Risk Models
Human mortality data are typically described
through a hazard rate A(a), which is the instantaneous
probability of an effect (e.g., death due to lung cancer)
at age a. This function then can be constructed in order
to describe the changing disease rates as a function of
an individual's age. For many human cancers, we find
that approximately X(a) = c a , where c is a constant
and k is a number in the range of4 to 6 depending upon
the cancer site and type. For an exposed group with
dose d, we model the hazard function as
X(a,d) = Xo(a) + AR(d) [1]
whereXo(a) isthe spontaneous (unexposed) hazardrate.
This additive risk model assumes that the increased
disease incidence is constant over time.
The second common model is the relative risk model:
X(a,d) = ko(a)RR(d) [2]
If either AR(d) or RR(d) is also dependent on age or
time of exposure, then one does not have an additive
or relative risk model, but a more complex situation.
The simple additive risk and relative risk models were
considered (1), and the relative risk model appeared to
describe the datain amuch moreadequate manner. The
risk estimates for extrapolating intime usingeitherthe
additive risk or relative risk model will produce signif-
icant differences. This problem has been recently dis-
cussed by Cohen (7).
To have a more general model, we can define the
relative risk to depend upon age and age-at-exposure
in the following manner:
RR(d) = 1 + f(d)g(a,e,t) [3]
where a = age, e = age-at-exposure, and t = a - e,
time-since-exposure. This is for a single exposure, as in
the A-bomb situation. This more complex relative risk
model relates to the multistage mutational model for
carcinogenesis, which has been described by Armitage
and Doll (8) and Peto (9). Themultistage model assumes
that the carcinogenic process is described by a finite
number of mutational stages and has been used to ex-
plain cancer datainboth animaland humanpopulations.
Ifwe assume thatthejth stage ofthe k stagesis affected
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Table 4. Cancer mortality among A-bomb survivors (1950-1982): age-sex effects.a
RRb at 100 rads
Male Female
Leukemia 3.84 4.08
Nonleukemia 1.11 1.25t
aFrom Preston et al. (3).
bRelative risk.
'Person-year-rads.
*p <0.05, 1.95 versus 1.20.
tp <0.01, 1.11 versus 1.25 and 1.6 versus 1.1.
Excess at 106 PYRC
Male Female
1.95 1.20*
3.29 4.42
Background rate
Female/male
0.54
0.57
RR at 100 rads,
age-at-exposure
0-19 20+
6.2 3.3
1.6 1.it
by an acute exposure ofradiation, then, as Whittemore
(10) has shown, the generalized relative risk model is
in the form
g(a,e,t) = exp{(k - j - 1)log(t) - [4]
(k - 1)log(a) + ( 1 - l)log(e)}
A few observations should be made with regard to
Equation 4. Ifthe first stage ofthe k stages is affected,
i.e., j = 1, then the relative risk term is simply a fac-
torable function ofthe individual's current age and time
since exposure anddoes notinvolve age-at-exposureper
se. If, however, the affected stage is the penultimate
stage, i.e., j = k - 1, then we see that the excess risk
is constant for any specified age-at-exposure. In other
words, we have an additive risk model. For the mul-
tistage model, however, we cannot have a constant ex-
cess relative risk, although there are situations where
one can come reasonably close numerically. Suppose,
for example, that an individual is exposed at the age of
20 and that there are five stages (k = 5) in the multis-
tage model. The ratio of the relative risk term as a
function of age varies over the range of ages in this
case, with the degree ofthe variability depending upon
whichstageisaffectedbytheradiation. Inthisexample,
ifthe third stage is affected, then the ratio ofthe great-
Table 5. Nonleukemia cancer mortality
among A-bomb survivors (1950-1982).a
Dose, Log Log
102 time age ATB20 City Sex Devianceb
Relative
risk 0.42 NSC NS -1.61 -0.79 1.25 1167
0.15 1.23 -3.13 NS -0.72 1.11 1164
0.13 S -2.38 S* -1.00 1.40 1174
0.24 0.66 -1.96 -0.69 -0.78 1.19 1163
Additive
risk 0.55 NS 3.16 -0.86 -0.82 0.81 1162
0.34 0.84 1.85 NS -0.73 0.61 1161
0.31 S 2.24 S -0.91 0.85 1168
0.46 0.54 2.52 -0.46 -0.76 0.67 1160
ag(e,a,t) = expallog(time/20) + a2log(age/50) + a3ATB20 + a4city
+ a5sex, where the tabled values are the coefficients al... a5.
ATB20 = 1 ifage at exposure is >20 years, city = 1 ifNagasaki, and
sex = 1 if male.
bMeasure ofmodel fit to data. A smaller value indicates a better fit.
'Nonsignificant.
*Statistically significant, p < 0.05.
est value ofthe relative risk term to the smallest value
after a 10-year latency (i.e., consider only the range of
ages 30-80) has a value of approximately 2. If, on the
other hand, the first stage is affected, then this ratio is
approximately 100. So, with actual epidemiological
data, one could possibly accept that the data are con-
sistent with a constant relative risk model, yet the data
may actually be consistent with a multistage model
where the third offive stages is the affected stage.
In an examination of the A-bomb cancer mortality
data, Hoel and Preston (11) considered the category of
epithelial tumors, which was defined as those tumors
that were neither hemopoietic nor hormonally related.
Theyshowedthatthemorecomplexrelativeriskmodels
provided the best description of the data. Also, the
choice ofmodel made a considerable difference in actual
risk estimates, especially for the younger exposed in-
dividuals where lifetime risk estimates could differ by
more than an order ofmagnitude. Table 5 shows fits to
the various relative risk and additive risk models for
the group of nonleukemia deaths. Looking at the rela-
tive risk fit, the data were well described by a model
that had both an age term and a time-since-exposure
term, butnotermforage-at-exposure. Apurelyrelative
risk model without a term for age-at-exposure did not
describe the data nearly as well as a model that either
incorporated age-at-exposure or time-since-exposure
and attained age. These data suggest that one cannot
determine whether the cancer effect is dependent upon
age-at-exposure or time-since-exposure and attained
age. Therefore, it may not be correct to conclude that
there is age susceptibility. This is a result of the co-
linearity of age, age-at-exposure, and time-since-ex-
posure; however, one can safely conclude that a purely
constantrelativeriskorpurelyadditive excessriskdoes
not describe the epithelial ornonleukemiatumorgroups
in the A-bomb survivors nearly as well as a more com-
plex model. Insofar as being consistent with the mul-
tistage model, the data are reasonably close, but are
not ofsufficient precision to allow more careful discrim-
ination between models.
These issues are currentlybeingdiscussed inthe area
ofradiation carcinogenic risk estimation and have a sig-
nificantbearingonthequantification ofrisk. Suchissues
indicate the complexity one faces when dealing with
other carcinogens, such as occupational exposures to
industrial chemicals and environmental agents. The is-
sues beyond simple dose response are important, and
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the lessons from ionizing radiation in human epide-
miology must be remembered in attempts to quantitate
human risk from situations where the data are consid-
erably limited, as contrasted with the radiation expe-
rience.
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